NeuroMetrix Enters Into Agreement with Simplex Healthcare for Distribution of the SENSUS Pain Management System WALTHAM, Mass. --(BUSINESS WIRE)--Sep. 24, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on management of chronic pain and peripheral neuropathies, today

NeuroMetrix to Present at Rodman & Renshaw Annual Global Investment Conference WALTHAM, Mass. --(BUSINESS WIRE)--Sep. 3, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on management of chronic pain and peripheral neuropathies, today announced that Shai N.

Focused on Building Broad Distribution Channel for SENSUS™

NeuroMetrix, Inc. Announces Date for 2013 Second Quarter Financial Results Conference Call WALTHAM, Mass. --(BUSINESS WIRE)--Jul. 17, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), today said it plans to issue its 2013 second quarter financial results before the opening of the market on July 25, 2013 .

Key Step Towards Positioning SENSUS for Sleep Market

Will Feature the SENSUS Pain Management System

NeuroMetrix Announces $5 Million Preferred Stock Placement WALTHAM, Mass. --(BUSINESS WIRE)--Jun. 4, 2013-- NeuroMetrix, Inc. (Nasdaq:NURO) (the "Company" or "NURO"), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today announced that

Launch of SENSUS™ Pain Management Device Highlights the Quarter

NeuroMetrix to Partner with Omron Healthcare for Distribution of NC-stat DPNCheck in Japan WALTHAM, Mass. --(BUSINESS WIRE)--Apr. 24, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment of diabetic peripheral neuropathy (DPN), announced that it had entered

NeuroMetrix, Inc. Announces Date for 2013 First Quarter Financial Results Conference Call WALTHAM, Mass. --(BUSINESS WIRE)--Apr. 17, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), today said it plans to issue its 2013 first quarter financial results before the opening of the market on April 25, 2013 .